8/28/2009

BioHelix will set up a 10,000-square-foot facility in Beverly, Mass., as it transitions from a research and development firm into a diagnostic test maker, CEO Huimin Kong said. The BioLabs spinoff, which makes tests for infectious and sexually transmitted diseases, hopes to push its first diagnostic product into clinical trials and submit it to the FDA within a couple of years, Kong said.

Related Summaries